Citation: T. Harrer et al., A new technique for cyclic in situ amplification and a case report about amplification of a single copy gene sequence in human metaphase chromosome through PCR-PRINS, HUM MUTAT, 17(2), 2001, pp. 131-140
Authors:
Fogarassy, E
de Unamuno, S
Prevot, B
Harrer, T
Maresch, S
Citation: E. Fogarassy et al., Experimental and numerical analysis of surface melt dynamics in 200 ns-excimer laser crystallization of a-Si films on glass, THIN SOL FI, 383(1-2), 2001, pp. 48-52
Authors:
Walter, H
Schmidt, B
Rascu, A
Helm, M
Moschik, B
Paatz, C
Kurowski, M
Korn, K
Uberla, K
Harrer, T
Citation: H. Walter et al., Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy, ANTIVIR TH, 5(4), 2000, pp. 249-256
Authors:
Van Laethem, K
Witvrouw, M
Balzarini, J
Schmit, JC
Sprecher, S
Hermans, P
Leal, M
Harrer, T
Ruiz, L
Clotet, B
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Authors:
Hauber, I
Harrer, T
Low, P
Schmitt, M
Schwingel, E
Hauber, J
Citation: I. Hauber et al., Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads, AIDS, 14(16), 2000, pp. 2619-2621
Authors:
Schmidt, B
Walter, H
Moschik, B
Paatz, C
van Vaerenbergh, K
Vandamme, AM
Schmitt, M
Harrer, T
Uberla, K
Korn, K
Citation: B. Schmidt et al., Simple algorithm derived from a geno-/phenotypic database to predict HIV-1protease inhibitor resistance, AIDS, 14(12), 2000, pp. 1731-1738
Authors:
Van Laethem, K
Van Vaerenbergh, K
Schmit, JC
Sprecher, S
Hermans, P
De Vroey, V
Schuurman, R
Harrer, T
Witvrouw, M
Van Wijngaerden, E
Stuyver, L
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Authors:
Grunke, M
Dechant, C
Low, P
Rascu, A
Kalden, JR
Harrer, T
Citation: M. Grunke et al., Hydroxyurea as part of a salvage regimen for heavily pretreated patients with advanced HIV infection, J ACQ IMM D, 21(5), 1999, pp. 424-426
Authors:
Walter, H
Schmidt, B
Korn, K
Vandamme, AM
Harrer, T
Uberla, K
Citation: H. Walter et al., Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors, J CLIN VIRO, 13(1-2), 1999, pp. 71-80
Authors:
Wagner, R
Leschonsky, B
Harrer, E
Paulus, C
Weber, C
Walker, BD
Buchbinder, S
Wolf, H
Kalden, JR
Harrer, T
Citation: R. Wagner et al., Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: Constraints on immune escape associated with targeting a sequence essential for viral replication, J IMMUNOL, 162(6), 1999, pp. 3727-3734
Authors:
Kolowos, W
Schmitt, M
Herrman, M
Harrer, E
Low, P
Kalden, JR
Harrer, T
Citation: W. Kolowos et al., Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones, J IMMUNOL, 162(12), 1999, pp. 7525-7533
Authors:
Harrer, T
Schwab, J
Struff, WG
Schmitt, M
Ficker, JH
Rodl, W
Parsch, H
Kalden, JR
Gramatzki, M
Citation: T. Harrer et al., Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS, INFECTION, 26(6), 1998, pp. 368-374